CLOUDIA RESEARCH SPA (AGAIN.MI) Stock Fundamental Analysis

BIT:AGAIN • IT0005577090

1.06 EUR
+0.01 (+0.95%)
Last: Jan 15, 2026, 07:00 PM
Fundamental Rating

4

Overall AGAIN gets a fundamental rating of 4 out of 10. We evaluated AGAIN against 65 industry peers in the IT Services industry. AGAIN has a bad profitability rating. Also its financial health evaluation is rather negative. AGAIN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AGAIN has reported negative net income.
  • In the past year AGAIN has reported a negative cash flow from operations.
AGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFAGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.44%, AGAIN is doing worse than 72.37% of the companies in the same industry.
  • AGAIN's Return On Equity of 0.93% is on the low side compared to the rest of the industry. AGAIN is outperformed by 71.05% of its industry peers.
  • AGAIN's Return On Invested Capital of 1.42% is on the low side compared to the rest of the industry. AGAIN is outperformed by 76.32% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AGAIN is in line with the industry average of 11.74%.
  • The 3 year average ROIC (13.42%) for AGAIN is well above the current ROIC(1.42%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.44%
ROE 0.93%
ROIC 1.42%
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
AGAIN.MI Yearly ROA, ROE, ROICAGAIN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • AGAIN's Profit Margin of 0.65% is on the low side compared to the rest of the industry. AGAIN is outperformed by 69.74% of its industry peers.
  • In the last couple of years the Profit Margin of AGAIN has grown nicely.
  • AGAIN has a Operating Margin of 1.77%. This is in the lower half of the industry: AGAIN underperforms 75.00% of its industry peers.
  • AGAIN's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 73.43%, AGAIN is doing good in the industry, outperforming 60.53% of the companies in the same industry.
  • AGAIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.77%
PM (TTM) 0.65%
GM 73.43%
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
AGAIN.MI Yearly Profit, Operating, Gross MarginsAGAIN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AGAIN is creating some value.
  • The number of shares outstanding for AGAIN has been increased compared to 1 year ago.
  • Compared to 1 year ago, AGAIN has an improved debt to assets ratio.
AGAIN.MI Yearly Shares OutstandingAGAIN.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
AGAIN.MI Yearly Total Debt VS Total AssetsAGAIN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of 1.60, we must say that AGAIN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AGAIN (1.60) is worse than 72.37% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that AGAIN is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.21, AGAIN is doing good in the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.6
ROIC/WACC0.12
WACC12.01%
AGAIN.MI Yearly LT Debt VS Equity VS FCFAGAIN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

  • AGAIN has a Current Ratio of 1.39. This is a normal value and indicates that AGAIN is financially healthy and should not expect problems in meeting its short term obligations.
  • AGAIN has a better Current ratio (1.39) than 64.47% of its industry peers.
  • A Quick Ratio of 1.39 indicates that AGAIN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.39, AGAIN is in the better half of the industry, outperforming 69.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
AGAIN.MI Yearly Current Assets VS Current LiabilitesAGAIN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M 4M 5M

7

3. Growth

3.1 Past

  • AGAIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.71%.
  • AGAIN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.26% yearly.
  • AGAIN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.46%.
  • AGAIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.87% yearly.
EPS 1Y (TTM)-97.71%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-145.41%
Revenue 1Y (TTM)16.46%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%12.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.75% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 14.73% on average over the next years. This is quite good.
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y18.75%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y14.73%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AGAIN.MI Yearly Revenue VS EstimatesAGAIN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 5M 10M 15M
AGAIN.MI Yearly EPS VS EstimatesAGAIN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Forward Earnings ratio of 2.47 indicates a rather cheap valuation of AGAIN.
  • Based on the Price/Forward Earnings ratio, AGAIN is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. AGAIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.47
AGAIN.MI Price Earnings VS Forward Price EarningsAGAIN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • AGAIN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AGAIN is cheaper than 61.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.95
AGAIN.MI Per share dataAGAIN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AGAIN's earnings are expected to grow with 27.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.92%
EPS Next 3Y27.23%

0

5. Dividend

5.1 Amount

  • No dividends for AGAIN!.
Industry RankSector Rank
Dividend Yield 0%

CLOUDIA RESEARCH SPA

BIT:AGAIN (1/15/2026, 7:00:00 PM)

1.06

+0.01 (+0.95%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners8.85%
Inst Owner ChangeN/A
Ins Owners41.2%
Ins Owner ChangeN/A
Market Cap5.52M
Revenue(TTM)7.25M
Net Income(TTM)47.50K
Analysts84.44
Price Target5.5 (418.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.47
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 2.62
EV/EBITDA 7.95
EPS(TTM)0
EYN/A
EPS(NY)0.43
Fwd EY40.49%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.39
BVpS0.98
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 0.93%
ROCE 1.9%
ROIC 1.42%
ROICexc 1.56%
ROICexgc 3.04%
OM 1.77%
PM (TTM) 0.65%
GM 73.43%
FCFM N/A
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
ROICexc(3y)16.46%
ROICexc(5y)N/A
ROICexgc(3y)20.34%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexgc growth 3Y-5.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y-19.06%
ROICexc growth 5YN/A
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 1.24
Cap/Depr 313.19%
Cap/Sales 31.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z 1.6
F-Score5
WACC12.01%
ROIC/WACC0.12
Cap/Depr(3y)372.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)28.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.71%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-145.41%
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y18.75%
Revenue 1Y (TTM)16.46%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%12.74%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y14.73%
EBIT growth 1Y-79.07%
EBIT growth 3Y41.54%
EBIT growth 5YN/A
EBIT Next Year108.4%
EBIT Next 3Y44.28%
EBIT Next 5Y35.79%
FCF growth 1Y10.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.03%
OCF growth 3YN/A
OCF growth 5YN/A

CLOUDIA RESEARCH SPA / AGAIN.MI FAQ

What is the fundamental rating for AGAIN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AGAIN.MI.


Can you provide the valuation status for CLOUDIA RESEARCH SPA?

ChartMill assigns a valuation rating of 5 / 10 to CLOUDIA RESEARCH SPA (AGAIN.MI). This can be considered as Fairly Valued.


What is the profitability of AGAIN stock?

CLOUDIA RESEARCH SPA (AGAIN.MI) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for AGAIN stock?

The Earnings per Share (EPS) of CLOUDIA RESEARCH SPA (AGAIN.MI) is expected to grow by 60.03% in the next year.